Trinity Biotech plc (TRIB)
USD 0.81
(-4.35%)
USD 0.81
(-4.35%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -24.01 Million USD | 41.42% |
| 2022 | -41 Million USD | -4785.94% |
| 2021 | 875 Thousand USD | 114.55% |
| 2020 | -6.01 Million USD | -47.88% |
| 2019 | -4.06 Million USD | -270.13% |
| 2018 | 2.39 Million USD | 105.93% |
| 2017 | -40.27 Million USD | 59.98% |
| 2016 | -100.62 Million USD | -561.67% |
| 2015 | 21.79 Million USD | 26.63% |
| 2014 | 17.21 Million USD | 66.52% |
| 2013 | 10.33 Million USD | -40.39% |
| 2012 | 17.34 Million USD | 11.21% |
| 2011 | 15.59 Million USD | -74.19% |
| 2010 | 60.41 Million USD | 410.98% |
| 2009 | 11.82 Million USD | 115.2% |
| 2008 | -77.77 Million USD | -119.89% |
| 2007 | -35.37 Million USD | -1179.73% |
| 2006 | 3.27 Million USD | -37.95% |
| 2005 | 5.28 Million USD | 2.21% |
| 2004 | 5.16 Million USD | -10.89% |
| 2003 | 5.79 Million USD | 15.71% |
| 2002 | 5.01 Million USD | 245.69% |
| 2001 | 1.44 Million USD | -69.95% |
| 2000 | 4.82 Million USD | -1.88% |
| 1999 | 4.91 Million USD | 89.07% |
| 1998 | 2.6 Million USD | 116.67% |
| 1997 | 1.2 Million USD | 233.33% |
| 1996 | -900 Thousand USD | -12.5% |
| 1995 | -800 Thousand USD | 75.76% |
| 1994 | -3.3 Million USD | 2.94% |
| 1993 | -3.4 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -6.75 Million USD | -103.71% |
| 2024 Q1 | -3.31 Million USD | 39.71% |
| 2023 Q1 | -6.3 Million USD | 37.43% |
| 2023 Q4 | -5.5 Million USD | 18.14% |
| 2023 Q3 | -6.72 Million USD | -12.24% |
| 2023 Q2 | -5.98 Million USD | 5.03% |
| 2023 FY | -24.01 Million USD | 41.42% |
| 2022 Q2 | -20.06 Million USD | -944.35% |
| 2022 Q4 | -10.07 Million USD | -12.66% |
| 2022 FY | -41 Million USD | -4785.94% |
| 2022 Q1 | -1.92 Million USD | -214.89% |
| 2022 Q3 | -8.94 Million USD | 55.42% |
| 2021 Q4 | 1.67 Million USD | 26.57% |
| 2021 Q1 | 1.6 Million USD | 115.98% |
| 2021 Q3 | 1.32 Million USD | 268.71% |
| 2021 FY | 875 Thousand USD | 114.55% |
| 2021 Q2 | -783 Thousand USD | -148.88% |
| 2020 Q2 | -1.46 Million USD | 33.98% |
| 2020 FY | -6.01 Million USD | -47.88% |
| 2020 Q3 | 7.32 Million USD | 599.32% |
| 2020 Q1 | -2.22 Million USD | 90.47% |
| 2020 Q4 | -10.02 Million USD | -236.85% |
| 2019 FY | -4.06 Million USD | -270.13% |
| 2019 Q2 | -5.4 Million USD | -2461.61% |
| 2019 Q1 | -211 Thousand USD | 99.12% |
| 2019 Q4 | -23.32 Million USD | -93388.0% |
| 2019 Q3 | 25 Thousand USD | 100.46% |
| 2018 Q1 | 378 Thousand USD | 100.88% |
| 2018 Q3 | 896 Thousand USD | 50.84% |
| 2018 Q4 | -23.95 Million USD | -2773.77% |
| 2018 Q2 | 594 Thousand USD | 57.14% |
| 2018 FY | 2.39 Million USD | 105.93% |
| 2017 FY | -40.27 Million USD | 59.98% |
| 2017 Q2 | 902 Thousand USD | -27.61% |
| 2017 Q3 | 445 Thousand USD | -50.67% |
| 2017 Q4 | -42.86 Million USD | -9732.13% |
| 2017 Q1 | 1.24 Million USD | 101.24% |
| 2016 Q3 | -517 Thousand USD | -124.57% |
| 2016 FY | -100.62 Million USD | -561.67% |
| 2016 Q2 | 2.1 Million USD | 256.2% |
| 2016 Q1 | -1.34 Million USD | -147.66% |
| 2016 Q4 | -100.86 Million USD | -19409.86% |
| 2015 Q1 | 4 Million USD | -2.81% |
| 2015 FY | 21.79 Million USD | 26.63% |
| 2015 Q3 | 12.26 Million USD | 355.2% |
| 2015 Q2 | 2.69 Million USD | -32.78% |
| 2015 Q4 | 2.82 Million USD | -76.96% |
| 2014 FY | 17.21 Million USD | 66.52% |
| 2014 Q1 | 4.41 Million USD | -8.67% |
| 2014 Q4 | 4.12 Million USD | -5.43% |
| 2014 Q3 | 4.36 Million USD | 1.07% |
| 2014 Q2 | 4.31 Million USD | -2.22% |
| 2013 Q4 | 4.83 Million USD | 270.5% |
| 2013 Q1 | 4.33 Million USD | -2.91% |
| 2013 FY | 10.33 Million USD | -40.39% |
| 2013 Q3 | -2.83 Million USD | -170.81% |
| 2013 Q2 | 4 Million USD | -7.77% |
| 2012 FY | 17.34 Million USD | 11.21% |
| 2012 Q4 | 4.46 Million USD | 0.2% |
| 2012 Q3 | 4.46 Million USD | 3.67% |
| 2012 Q2 | 4.3 Million USD | 4.67% |
| 2012 Q1 | 4.11 Million USD | 1.63% |
| 2011 Q4 | 4.04 Million USD | 2.77% |
| 2011 Q3 | 3.93 Million USD | 1.89% |
| 2011 Q1 | 3.75 Million USD | 2.51% |
| 2011 Q2 | 3.86 Million USD | 2.93% |
| 2011 FY | 15.59 Million USD | -74.19% |
| 2010 Q2 | 50.68 Million USD | 1505.38% |
| 2010 Q1 | 3.15 Million USD | -3.1% |
| 2010 Q3 | 2.91 Million USD | -94.24% |
| 2010 Q4 | 3.66 Million USD | 25.39% |
| 2010 FY | 60.41 Million USD | 410.98% |
| 2009 Q1 | 2.5 Million USD | 103.07% |
| 2009 FY | 11.82 Million USD | 115.2% |
| 2009 Q2 | 3 Million USD | 20.01% |
| 2009 Q3 | 3.05 Million USD | 1.73% |
| 2009 Q4 | 3.25 Million USD | 6.58% |
| 2008 Q2 | 1.5 Million USD | 43.85% |
| 2008 Q3 | 1.32 Million USD | -12.46% |
| 2008 Q4 | -81.65 Million USD | -6281.45% |
| 2008 FY | -77.77 Million USD | -119.89% |
| 2008 Q1 | 1.04 Million USD | -98.23% |
| 2007 Q3 | -30.14 Million USD | -1253.29% |
| 2007 Q4 | 59.35 Million USD | 296.89% |
| 2007 Q2 | 2.61 Million USD | -10.2% |
| 2007 Q1 | 2.91 Million USD | 82.17% |
| 2007 FY | -35.37 Million USD | -1179.73% |
| 2006 Q2 | -2.11 Million USD | -270.46% |
| 2006 Q1 | 1.23 Million USD | -14.79% |
| 2006 Q3 | 2.55 Million USD | 220.79% |
| 2006 Q4 | 1.59 Million USD | -37.36% |
| 2006 FY | 3.27 Million USD | -37.95% |
| 2005 Q3 | 1.6 Million USD | 31.77% |
| 2005 Q2 | 1.21 Million USD | 21.44% |
| 2005 Q1 | 1 Million USD | -42.52% |
| 2005 FY | 5.28 Million USD | 2.21% |
| 2005 Q4 | 1.45 Million USD | -9.41% |
| 2004 Q4 | 1.74 Million USD | 16.02% |
| 2004 Q1 | 707 Thousand USD | 30.81% |
| 2004 Q2 | 1.21 Million USD | 71.29% |
| 2004 Q3 | 1.5 Million USD | 24.19% |
| 2004 FY | 5.16 Million USD | -10.89% |
| 2003 Q3 | 1.8 Million USD | 3.02% |
| 2003 Q4 | 540.47 Thousand USD | -70.12% |
| 2003 Q1 | 1.69 Million USD | 12.4% |
| 2003 FY | 5.79 Million USD | 15.71% |
| 2003 Q2 | 1.75 Million USD | 3.78% |
| 2002 FY | 5.01 Million USD | 245.69% |
| 2002 Q2 | 1.12 Million USD | -8.29% |
| 2002 Q3 | 1.14 Million USD | 1.42% |
| 2002 Q1 | 1.23 Million USD | 174.17% |
| 2002 Q4 | 1.5 Million USD | 31.47% |
| 2001 FY | 1.44 Million USD | -69.95% |
| 2001 Q4 | -1.65 Million USD | -248.58% |
| 2001 Q3 | 1.11 Million USD | 10.81% |
| 2001 Q2 | 1 Million USD | 2.44% |
| 2001 Q1 | 984 Thousand USD | 1038.03% |
| 2000 Q2 | 1.6 Million USD | 14.35% |
| 2000 Q1 | 1.4 Million USD | -18.34% |
| 2000 Q3 | 1.73 Million USD | 8.3% |
| 2000 FY | 4.82 Million USD | -1.88% |
| 2000 Q4 | 86.46 Thousand USD | -95.02% |
| 1999 Q2 | 1.1 Million USD | 22.22% |
| 1999 Q4 | 1.71 Million USD | 42.97% |
| 1999 FY | 4.91 Million USD | 89.07% |
| 1999 Q1 | 900 Thousand USD | 0.0% |
| 1999 Q3 | 1.2 Million USD | 9.09% |
| 1998 Q2 | 600 Thousand USD | 20.0% |
| 1998 FY | 2.6 Million USD | 116.67% |
| 1998 Q3 | 700 Thousand USD | 16.67% |
| 1998 Q1 | 500 Thousand USD | 25.0% |
| 1998 Q4 | 900 Thousand USD | 28.57% |
| 1997 Q2 | 300 Thousand USD | 50.0% |
| 1997 Q3 | 400 Thousand USD | 33.33% |
| 1997 FY | 1.2 Million USD | 233.33% |
| 1997 Q4 | 400 Thousand USD | 0.0% |
| 1997 Q1 | 200 Thousand USD | 0.0% |
| 1996 Q1 | - USD | 100.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 FY | -900 Thousand USD | -12.5% |
| 1996 Q2 | - USD | 0.0% |
| 1995 Q2 | -100 Thousand USD | 66.67% |
| 1995 Q3 | -100 Thousand USD | 0.0% |
| 1995 FY | -800 Thousand USD | 75.76% |
| 1995 Q4 | -300 Thousand USD | -200.0% |
| 1995 Q1 | -300 Thousand USD | 0.0% |
| 1994 Q3 | -1.1 Million USD | 0.0% |
| 1994 FY | -3.3 Million USD | 2.94% |
| 1994 Q2 | -1.1 Million USD | -57.14% |
| 1994 Q1 | -700 Thousand USD | 22.22% |
| 1993 Q4 | -900 Thousand USD | 0.0% |
| 1993 Q2 | -900 Thousand USD | 0.0% |
| 1993 FY | -3.4 Million USD | 0.0% |
| 1993 Q3 | -900 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 89.669% |
| Prenetics Global Limited | -62.72 Million USD | 61.708% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -1451.55% |
| CareDx, Inc | -190.28 Million USD | 87.378% |
| Exact Sciences Corporation | -204.14 Million USD | 88.235% |
| Exagen Inc. | -23.68 Million USD | -1.389% |
| Inotiv, Inc. | -105.14 Million USD | 77.156% |
| Guardant Health, Inc. | -479.44 Million USD | 94.99% |
| Biodesix, Inc. | -52.14 Million USD | 53.941% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -813.564% |
| Precipio, Inc. | -5.85 Million USD | -310.354% |
| iSpecimen Inc. | -11.09 Million USD | -116.388% |
| Natera, Inc. | -434.8 Million USD | 94.476% |
| Aspira Women's Health Inc. | -16.69 Million USD | -43.907% |
| Standard BioTools Inc. | -74.65 Million USD | 67.828% |
| 23andMe Holding Co. | -666.7 Million USD | 96.398% |
| Castle Biosciences, Inc. | -57.46 Million USD | 58.205% |
| Personalis, Inc. | -108.29 Million USD | 77.822% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 72.855% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -141.458% |
| OpGen, Inc. | -32.66 Million USD | 26.48% |
| T2 Biosystems, Inc. | -50.07 Million USD | 52.038% |
| Myriad Genetics, Inc. | -112 Million USD | 78.555% |
| ICON Public Limited Company | 612.33 Million USD | 103.922% |
| NeoGenomics, Inc. | -87.96 Million USD | 72.697% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -1451.55% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 102.842% |
| RadNet, Inc. | 3.04 Million USD | 889.028% |
| MDxHealth SA | -43.1 Million USD | 44.274% |
| Psychemedics Corporation | -4.15 Million USD | -478.19% |
| Illumina, Inc. | -1.16 Billion USD | 97.931% |
| Check-Cap Ltd. | -17.56 Million USD | -36.714% |
| Twist Bioscience Corporation | -208.72 Million USD | 88.493% |
| DarioHealth Corp. | -59.42 Million USD | 59.584% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 85.689% |
| Sera Prognostics, Inc. | -36.24 Million USD | 33.729% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -138.742% |
| OPKO Health, Inc. | -188.86 Million USD | 87.283% |
| Medpace Holdings, Inc. | 282.81 Million USD | 108.493% |
| Neogen Corporation | -9.42 Million USD | -154.941% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -136.473% |
| Prenetics Global Limited | -62.72 Million USD | 61.708% |
| Mainz Biomed B.V. | -26.29 Million USD | 8.662% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -202.608% |
| Neuronetics, Inc. | -30.18 Million USD | 20.441% |
| Sotera Health Company | 51.37 Million USD | 146.749% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -202.608% |